Evergy (EVRG) Q1 2025 Earnings Call May 08, 2025 09:00 AM ET Company Participants Peter Flynn - Director of Investor RelationsDavid Campbell - Chairman, President, Director & CEOBryan Buckler - EVP & CFODurgesh Chopra - Managing DirectorNathan Richardson - AVP - Equity ResearchTanner James - VP - North America Power, Utilities, and Clean Energy Research Conference Call Participants Travis Miller - AnalystPaul Cole - Equity Analyst Operator Good day and thank you for standing by. Welcome to the Evergy Q1 twe ...

Evergy (EVRG) Q1 2025 Earnings Call May 08, 2025 09:00 AM ET Speaker0 Good Speaker1 day and thank you for standing by. Welcome to the Evergy Q1 twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone. You will then hear an automated message advising that your hand is raised. To withdraw your question, p ...

Evergy, Inc. (EVRG) reported first-quarter 2025 operating earnings per share (EPS) of 54 cents, which lagged the Zacks Consensus Estimate of 66 cents by 18.2%. In the year-ago quarter, the company reported earnings of 54 cents per share. (See the Zacks Earnings Calendar to stay ahead of market-making news.)First-quarter adjusted EPS was driven by the recovery of regulated investments, partially offset by lower demand resulting from an unplanned customer maintenance shutdown and the impact of leap year durin ...

Evergy Inc (EVRG) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.54 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -18.18%. A quarter ago, it was expected that this electric utility would post earnings of $0.36 per share when it actually produced earnings of $0.35, delivering a surprise of -2.78%.Over the last four quarters, the com ...

May 8, 2025 First Quarter 2025 Earnings Call Important Information Forward Looking Statements Statements made in this document that are not based on historical facts are forward-looking, may involve risks and uncertainties, and are intended to be as of the date when made. Forward-looking statements include, but are not limited to, statements relating to Evergy's strategic plan, including, without limitation, those related to earnings per share, dividend, operating and maintenance expense and capital investm ...

NEWS RELEASE Exhibit 99.1 Evergy Announces First Quarter 2025 Results, Declares Quarterly Dividend and Reaffirms 2025 Guidance "We are reaffirming our 2025 adjusted EPS guidance range and remain laser-focused on delivering against our financial targets while delivering affordable and reliable electric service to our 1.7 million customers," Campbell continued. "Our long-term outlook remains bright - relative to our size, the backlog for large customers evaluating Kansas and Missouri is one of the most robust ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | | Exact name of registrant as specified in its charter, | | | --- | --- | --- | | Commission | state of incorporation, address of principal | I.R.S. Employer | | File Number | executive offices and telephone number | Identification Number | | 001-38515 | EVERGY, INC. | 82-2733395 | | | (a Missouri corporation) | | | | 1200 Main Street | | | | Kansas City, Missouri 64105 | | | | (816) 556-2200 | | | 001-03523 | EVERGY ...

The market expects Evergy Inc (EVRG) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released o ...

In dividend growth investing, I would argue that consistency is what matters the most. When I either buy a stock for my portfolio or cover it as an analyst, I have to beHi, my name is Kody. Aside from my articles here on Seeking Alpha, I am also a regular contributor to Sure Dividend, The Dividend Kings, and iREIT+Hoya Capital. I have been investing since September 2017 (age 20) and interested in dividend investing since about 2009.Since July 2018, I have ran Kody's Dividends. This is a blog that is documen ...

Core Viewpoint - The stock market is experiencing significant declines, reminiscent of the COVID-19 sell-off in 2020, with a looming global trade war and increased recession probabilities due to President Trump's new tariffs [1]. Group 1: Company Analysis - Kroger - Kroger's stock has risen approximately 14% despite the overall market downturn, indicating resilience [3]. - The company acknowledges potential tariff impacts, particularly on its produce business, but expects only a mid-single-digit percentage effect [4]. - Kroger is likely to perform well even in a recession, as grocery shopping remains essential, potentially increasing sales of its private-label products [5]. - Management expresses a proactive approach to tariffs, viewing them as an opportunity rather than a significant threat [6]. Group 2: Company Analysis - Evergy - Evergy, a utility company serving 1.7 million customers, has shown gains this year and is well-positioned amidst new tariffs [7]. - The company has a market cap of approximately $15.7 billion and a projected net income of $873.5 million for 2024, with a robust backlog of growth opportunities [8]. - There was no mention of tariffs in Evergy's earnings call, suggesting minimal impact from trade policies, and the company is expected to continue providing dividends with a yield over 3.8% [9]. Group 3: Company Analysis - Vertex Pharmaceuticals - Vertex Pharmaceuticals has seen its stock rise nearly 20% year-to-date, demonstrating strong performance amid tariff concerns [10]. - The company specializes in therapies for cystic fibrosis and is expanding its product line with new treatments, which are unlikely to be affected by tariffs [11]. - Vertex's pipeline includes several late-stage programs that could lead to significant revenue, including a potential cure for severe type 1 diabetes [13].